Skip Navigation

Discussions

Research / Clinical Trials

Connect with others to share experiences, questions, and insights about research and clinical trials.
360Coach Brandon

🫁 Bronchiectasis Care Is Changing! What Do the New Guidelines Mean for You? 

There's a lot happening in the world of bronchiectasis research and treatment, and I wanted to share a video that takes a closer look at some of those changes!

In September, experts from the United States and Europe came together to discuss the new 2025 European bronchiectasis treatment guidelines and how they may influence the care people receive on both sides of the Atlantic.

Now, I know the word guidelines can sound a little intimidating, but they're really recommendations that help healthcare professionals make decisions about the best ways to treat and manage a condition.

This discussion looks at some important questions:

What are the latest recommendations for treating bronchiectasis?

When might long-term antibiotics or inhaled antibiotics be helpful?

Are there treatments that may not be recommended for everyone?

Why might treatment options and access to medications differ between the United States and Europe?

How might future treatments become more personalized to each patient's needs?

What I really like about this discussion is that it looks beyond the research and talks about how these recommendations may affect actual patient care.

The video is about an hour long, and while some of the discussion gets technical, there's a lot of valuable information about where bronchiectasis treatment is headed.

🎥 Watch the video here:

https://channel.ersnet.org/media-121507-bronchiectasis-across-the-atlantic-implementing-the-2025-ers-guidelines-in-us-and-european-practice-28-september-2026

As always, treatment decisions should be made with your healthcare team, but understanding what's changing can help you feel more informed and prepared for those conversations.

Have you and your healthcare provider talked about any of the newer bronchiectasis treatment recommendations? We'd love to hear what you've been learning!


1 month ago
M

Hi everyone, I watched Dr. Chalmers highlights from the European Respiratory Society Congress today. He mentioned the BEST study, a research study following people on Brensocatib. Does anyone have any information on this? I’d like to be involved. Thanks! 
Maggie 

2 months ago
K


Hello! National Patient Advocacy Day was on August 19th. Patient advocacy is a key function in the healthcare system that focuses on advocating for patients, and caregivers.  In the United States, patient advocacy became prominent in the 1950s, with cancer research and treatment.

As the Patient Rights movement grew in the United States, the 1970s were a pivotal period for patient activism. An example of this activism is the American Hospital Association’s Patient Bill of Rights.  Individual patient advocacy gained traction in the United States in the early 2000s. 
The COPDF and the BNTM Association organizes an event, known as Impact that is held every March in Washington, DC. Meeting with your legislators on Capitol Hill is truly a great experience. 
Below is a link for more information on Impact Day, including the priority requests  that have been made since 2019. https://www.copdfoundation.org/Take-Action/Get-Involved/IMPACT-Lung-Health.aspx

Please let us know if you have any questions. This event offers the opportunity of taking action to assist in moving research and the development of new drugs and treatments forward. Contact information is included in the link above if you are interested in getting involved. :) 

2 months ago
D

BiomX just dropped a study for a drug to treat Pseudomonas, which was disappointing, but Clarametyx is now also working on clinical trials for a drug to treat Pseudomonas in the lung. Here is a link from a recent news release if you haven't seen it.

https://clarametyx.com/clarametyx-biosciences-anno...

7 months ago
A

Help uncover the challenges of Non-Cystic Fibrosis Bronchiectasis (NCFBE).

The BURDEN initiative by Insmed Incorporated is seeking adults with NCFBE and caregivers for interviews. Your participation in the BURDEN initiative interviews is crucial for raising awareness about the real-life impact of Non-Cystic Fibrosis Bronchiectasis (NCFBE). By sharing your experiences, you help improve understanding, care, and resources for adults living with bronchiectasis (without cystic fibrosis), also known as NCFBE, and their caregivers.

2 years ago

M

I know a couple of patients interested in joining the Bronchiectasis and NTM Research Registry - How can they join?

10 years ago
L

What is the Bronchiectasis and NTM Research Registry? Is it the same as this online community? Is it something I should be a part of?

10 years ago

It is not our intention to serve as a substitute for medical advice and any content posted should not be used for medical advice, diagnosis or treatment. We make every effort to support our members, our medical professionals cannot and will not provide a diagnosis or suggest a specific medication; those decisions should be left to your personal medical team. While we encourage individuals to share their personal experiences with Bronchiectasis and NTM, please consult a physician before making changes to your own Bronchiectasis and NTM management plan.

Community posts are monitored by the 360social Community Manager, as well as staff respiratory therapists, educators, and other medical professionals.

An unhandled error has occurred. Reload 🗙

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.